BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11149245)

  • 1. Antitumor effect and peritumoral brain edema formation in relation to MX2, ACNU, and doxorubicin therapy: a comparative analysis using rodent models of gliomas.
    Mima T; Mostafa MG; Mori K
    Neurol Res; 2000 Dec; 22(8):819-24. PubMed ID: 11149245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution.
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R
    Neurosurgery; 1995 Sep; 37(3):471-6; discussion 476-7. PubMed ID: 7501112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
    Kiya K; Ogasawara H; Fujita H; Sugiyama K; Kurisu K; Kawamoto K; Uozumi T; Shinkai H
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):631-5. PubMed ID: 8470921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor effect of a new anthracycline derivative, MX2, against human glioma cells].
    Kuratsu J; Mihara Y; Kochi M; Takaki S; Ushio Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):399-403. PubMed ID: 2930204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of MX2, a new morpholino anthracycline, against experimental brain tumors.
    Izumoto S; Arita N; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Ushio Y
    Anticancer Res; 1990; 10(3):735-9. PubMed ID: 2369088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor effect of MX2, a new morpholino anthracycline against C6 glioma cells and its combination effect with photodynamic therapy in vitro].
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R; Uno H; Kodera T
    No To Shinkei; 1995 Oct; 47(10):969-73. PubMed ID: 7577142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination effect of hyperthermia and MX2 on cultured glioma cell lines].
    Mizumatsu S; Ono Y; Tamiya T; Matsumoto K; Ohmoto T; Furuta T
    Gan To Kagaku Ryoho; 1999 May; 26(6):789-95. PubMed ID: 10410148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
    Park SJ; Kaye AH; Hill JS
    J Clin Neurosci; 2000 Jan; 7(1):42-7. PubMed ID: 10847650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor efficacy of FK 973 on malignant glioma cells].
    Shimizu K; Yamada M; Mabuchi E; Matsui Y; Tamura K; Moriuchi S; Park K; Mogami H
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2367-72. PubMed ID: 2751317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
    Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
    Izumoto S; Arita N; Ushio Y; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Oku Y; Mogami H; Komeshima N
    Gan To Kagaku Ryoho; 1988 May; 15(5):1765-9. PubMed ID: 3369870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice.
    Lu Z; Ma J; Liu B; Dai C; Xie T; Ma X; Li M; Dong J; Lan Q; Huang Q
    Cancer Med; 2016 Nov; 5(11):3147-3155. PubMed ID: 27734611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapeutic strategy in rat brain tumor cells resistant to ACNU using an in vitro colony formation assay].
    Mineura K; Sasaki J; Fushimi S; Sasajima H; Ishino Y; Kowada M
    No To Shinkei; 1989 Sep; 41(9):927-32. PubMed ID: 2590562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug sensitivity test against malignant gliomas].
    Nakamura O; Matsutani M; Nomura K; Takakura K
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1151-6. PubMed ID: 1693488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of O6-methylguanine or O6-benzylguanine in the enhancement of chloroethylnitrosourea cytotoxicity on brain tumours.
    Mineura K; Izumi I; Watanabe K; Kowada M; Kohda K; Ikenaga M
    Acta Neurochir (Wien); 1994; 128(1-4):13-20. PubMed ID: 7847129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circumvention of ACNU-resistance in rat glioma cells by pretreatment with O6-methylguanine].
    Mineura K; Fushimi S; Sasaki J; Sasajima H; Ishino Y; Kowada M
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):259-62. PubMed ID: 2919893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of single-bolus vs. frequent low-dose treatment with nitrosourea in experimental gliomas.
    Wu CM; Inamura T; Ikezaki K; Nakamizo A; Inoha S; Yaosaka F; Fukui M
    Anticancer Res; 2001; 21(3B):1835-8. PubMed ID: 11497267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chloroethylating anticancer drug ACNU induces FRA1 that is involved in drug resistance of glioma cells.
    Meise R; Tomicic MT; Kaina B; Christmann M
    Biochim Biophys Acta; 2012 Jul; 1823(7):1199-207. PubMed ID: 22609303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal chemotherapy with MX2 for treating glioma dissemination in vivo.
    Mizumatsu S; Matsumoto K; Ono Y; Tamiya T; Furuta T; Ohmoto T
    J Neurooncol; 2000 Aug; 49(1):41-7. PubMed ID: 11131985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
    Yoshida T; Ushio Y; Hayakawa T; Yamada K; Kato A; Mogami H; Nakata Y
    No Shinkei Geka; 1984 Aug; 12(9):1029-36. PubMed ID: 6594599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.